S.Biomedics Co., Ltd. (KOSDAQ: 304360)

S.Biomedics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,911	1,410	4,066	6,131	9,188	3,426
Short-Term Investments	3,376	8,175	2,346	6,750	3,000	2,010
Trading Asset Securities	3,251	1,073	1,007	-	259.94	10,157
Cash & Short-Term Investments	8,539	10,658	7,419	12,881	12,448	15,593
Cash Growth	-48.37%	43.66%	-42.41%	3.48%	-20.17%	-3.22%
Accounts Receivable	1,141	1,922	1,246	388.8	713.77	779.5
Other Receivables	-	198.83	204.02	67.26	65.95	82.84
Receivables	1,141	2,211	1,540	456.07	789.71	862.34
Inventory	3,064	2,369	1,570	763.73	707.72	616.54
Prepaid Expenses	-	336.37	426	174.46	254.73	267.01
Other Current Assets	403.7	126.94	245.98	66.43	121.3	94.79
Total Current Assets	13,147	15,700	11,201	14,342	14,322	17,433
Property, Plant & Equipment	4,062	4,962	2,765	3,051	3,357	4,489
Long-Term Investments	500	1,533	1,000	0.06	0.04	0.02
Other Intangible Assets	101.29	118.78	153.76	25.44	19.32	16.85
Long-Term Deferred Tax Assets	343.07	358.55	412.76	-	-	-
Other Long-Term Assets	11,032	9,275	8,825	377.05	366.79	344.28
Total Assets	29,184	31,947	24,358	17,796	18,065	22,283
Accounts Payable	295.97	479.48	416.17	36.31	505.44	579.12
Accrued Expenses	-	294.48	253.98	182.96	138.66	94.87
Short-Term Debt	2,975	3,547	5,807	1,916	3,231	2,319
Current Portion of Long-Term Debt	345.36	338.51	331.66	96.02	88.94	91.12
Current Portion of Leases	881.6	804.99	442.6	492.23	441.04	441.76
Current Income Taxes Payable	11.74	39.1	13.46	-	-	-
Current Unearned Revenue	-	4.32	4.28	7.53	7.58	191.93
Other Current Liabilities	4,880	2,223	4,562	1,444	2,350	1,829
Total Current Liabilities	9,389	7,731	11,831	4,175	6,763	5,547
Long-Term Debt	6,360	6,480	7,008	3,783	1,392	798.3
Long-Term Leases	496.09	824.86	206.79	520.66	449.83	867.93
Long-Term Unearned Revenue	-	2,050	2,054	2,058	2,062	1,067
Other Long-Term Liabilities	2,951	932.98	622.38	2,058	1,480	441.49
Total Liabilities	21,138	19,672	23,323	13,964	13,265	9,544
Common Stock	5,737	5,669	5,110	5,110	5,075	1,251
Additional Paid-In Capital	63,367	61,926	44,478	44,478	43,936	46,748
Retained Earnings	-71,372	-65,472	-57,759	-51,485	-45,844	-38,106
Comprensive Income & Other	4,494	4,809	4,393	4,408	2,649	3,107
Total Common Equity	2,225	6,932	-3,779	2,510	5,816	12,999
Minority Interest	5,821	5,343	4,814	1,321	-1,017	-260.27
Shareholders' Equity	8,047	12,275	1,035	3,832	4,800	12,739
Total Liabilities & Equity	29,184	31,947	24,358	17,796	18,065	22,283
Total Debt	11,058	11,995	13,796	6,808	5,602	4,518
Net Cash (Debt)	-2,519	-1,337	-6,377	6,073	6,846	11,074
Net Cash Growth	-	-	-	-11.29%	-38.18%	-13.77%
Net Cash Per Share	-221.74	-122.35	-624.02	598.26	677.20	1138.55
Filing Date Shares Outstanding	11.47	11.34	10.22	10.22	10.15	2.5
Total Common Shares Outstanding	11.47	11.34	10.22	10.22	10.15	2.5
Working Capital	3,757	7,969	-629.62	10,167	7,559	11,886
Book Value Per Share	193.94	611.43	-369.73	245.64	573.05	5194.69
Tangible Book Value	2,124	6,813	-3,932	2,485	5,797	12,983
Tangible Book Value Per Share	185.12	600.95	-384.77	243.15	571.15	5187.96
Land	241.82	241.82	241.82	117.16	117.16	117.16
Buildings	558.2	558.2	558.2	349.29	349.29	349.29
Machinery	6,130	6,061	4,849	4,552	4,091	3,840
Construction In Progress	435	829.26	441.24	42.5	5.4	2.9

Source: S&P Capital IQ. Standard template. Financial Sources.